Skip to main content
. 2021 Mar;10(3):1284–1294. doi: 10.21037/tcr-20-2568

Figure 2.

Figure 2

Effects of TTN/TP53 double mutation on OS of LUSC patients on chemotherapy. (A) Patients with TTN/TP53 double mutation, TTN and TP53 single mutation in LUAD. (B) Number of patients with TTN/TP53 double mutation, TTN and TP53 single mutation in LUSC. (C) The difference in OS period between TTN/TP53 double mutation and single mutation of TTN or TP53 in LUAD. (D) The difference in OS period between TTN/TP53 double mutation and single mutation of TTN or TP53 in LUSC. “+” indicates MT; “–” indicates WT. TTN, titin; TP53, tumor protein 53; OS, overall survival; LUAD, lung adenocarcinoma; LUSC, lung squamous carcinoma; MT, mutant-type; WT, wild-type.